Neurotoxicology of Synthetic Cathinone Analogs.

The present review briefly explores the neurotoxic properties of methcathinone, mephedrone, methylone, and methylenedioxypyrovalerone (MDPV), four synthetic cathinones most commonly found in "bath salts." Cathinones are β-keto analogs of the commonly abused amphetamines and display pharmacological effects resembling cocaine and amphetamines, but despite their commonalities in chemical structures, synthetic cathinones possess distinct neuropharmacological profiles and produce unique effects. Among the similarities of synthetic cathinones with their non-keto analogs are their targeting of monoamine systems, the release of neurotransmitters, and their stimulant properties. Most of the literature on synthetic cathinones has focused on describing their properties as psychostimulants, their behavioral effects on locomotion, memory, and potential for abuse, whereas descriptions of their neurotoxic properties are not abundant. The biochemical gauges of neurotoxicity induced by non-keto analogs are well studied in humans and experimental animals and include their ability to induce neuroinflammation, oxidative stress, excitotoxicity, temperature alterations as well as dysregulation of neurotransmitter systems and induce changes in monoamine transporters and receptors. These neurotoxicity gauges will serve as parameters to discuss the effects of the four previously mentioned synthetic cathinones alone or in combination with either another cathinone or with some of their non-keto analogs. Bath salts are not a defined combination of drugs and may consist of one synthetic cathinone compound or combinations of more cathinones. Furthermore, this review also presents some of the mechanisms that are thought to underlie this toxicity. A better understanding of the cellular and molecular mechanisms involved in the synthetic cathinones-induced neurotoxicity should contribute to generate modern therapeutic approaches to prevent or attenuate the adverse consequences of use of these drugs in humans.

[1]  J. Ramsey,et al.  High levels of intravenous mephedrone (4-methylmethcathinone) self-administration in rats: Neural consequences and comparison with methamphetamine , 2013, Journal of psychopharmacology.

[2]  J. Cadet,et al.  Neurotoxicity of substituted amphetamines: Molecular and cellular mechanisms , 2007, Neurotoxicity Research.

[3]  M. Kane,et al.  Effects of combined treatment with mephedrone and methamphetamine or 3,4-methylenedioxymethamphetamine on serotonin nerve endings of the hippocampus. , 2014, Life sciences.

[4]  R. Rockhold,et al.  Methcathinone intoxication in the rat: abrogation by dextrorphan. , 1997, Annals of emergency medicine.

[5]  R. Glennon,et al.  "Deconstruction" of the abused synthetic cathinone methylenedioxypyrovalerone (MDPV) and an examination of effects at the human dopamine transporter. , 2013, ACS chemical neuroscience.

[6]  B. Yamamoto,et al.  Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists. , 1994, European journal of pharmacology.

[7]  A. Riley,et al.  3,4-Methylenedioxypyrovalerone (MDPV)-induced conditioned taste avoidance in the F344/N and LEW rat strains , 2014, Pharmacology Biochemistry and Behavior.

[8]  J. Cadet,et al.  Invited Review Free radicals and the pathobiology of brain dopamine systems , 1998, Neurochemistry International.

[9]  A. Ruoho,et al.  Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines , 1999 .

[10]  W. Slikker,et al.  Methamphetamine‐Induced Dopaminergic Neurotoxicity: Role of Peroxynitrite and Neuroprotective Role of Antioxidants and Peroxynitrite Decomposition Catalysts , 2001, Annals of the New York Academy of Sciences.

[11]  D. Wong,et al.  Reduced Striatal Dopamine Transporter Density in Abstinent Methamphetamine and Methcathinone Users: Evidence from Positron Emission Tomography Studies with [11C]WIN-35,428 , 1998, The Journal of Neuroscience.

[12]  A. Csillag,et al.  Apoptotic effects of the 'designer drug' methylenedioxypyrovalerone (MDPV) on the neonatal mouse brain. , 2014, Neurotoxicology.

[13]  R. Glennon,et al.  Synthetic cathinones: chemical phylogeny, physiology, and neuropharmacology. , 2014, Life sciences.

[14]  H. Sitte,et al.  Amphetamines, new psychoactive drugs and the monoamine transporter cycle , 2014, Trends in pharmacological sciences.

[15]  T. Robinson,et al.  Amphetamine‐Induced time‐dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: A microdialysis study in behaving rats , 1995, Synapse.

[16]  K. T. Wakabayashi,et al.  Effects of Social Interaction and Warm Ambient Temperature on Brain Hyperthermia Induced by the Designer Drugs Methylone and MDPV , 2015, Neuropsychopharmacology.

[17]  M. Reith,et al.  Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter. , 2015, Drug and alcohol dependence.

[18]  O. Hornykiewicz,et al.  Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. , 1995, Molecular pharmacology.

[19]  F. Ebling,et al.  Behavioural and neurochemical comparison of chronic intermittent cathinone, mephedrone and MDMA administration to the rat , 2013, European Neuropsychopharmacology.

[20]  E. Kiyatkin,et al.  Acute methamphetamine intoxication: brain hyperthermia, blood-brain barrier, brain edema, and morphological cell abnormalities. , 2009, International review of neurobiology.

[21]  J. Camarasa,et al.  Dose and Time-Dependent Selective Neurotoxicity Induced by Mephedrone in Mice , 2014, PloS one.

[22]  A. Winstock,et al.  Mephedrone in Adolescent Rats: Residual Memory Impairment and Acute but Not Lasting 5-HT Depletion , 2012, PloS one.

[23]  D. Kuhn,et al.  3,4‐Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine‐induced damage to dopamine nerve endings: β‐ketoamphetamine modulation of neurotoxicity by the dopamine transporter , 2015, Journal of neurochemistry.

[24]  H. Haughey,et al.  Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia. , 2000, The Journal of pharmacology and experimental therapeutics.

[25]  J. Benjamins,et al.  Methamphetamine Neurotoxicity in Dopamine Nerve Endings of the Striatum Is Associated with Microglial Activation , 2004, Journal of Pharmacology and Experimental Therapeutics.

[26]  M. Gygi,et al.  Role of endogenous dopamine in the neurochemical deficits induced by methcathinone. , 1997, The Journal of pharmacology and experimental therapeutics.

[27]  Jorge Camarasa,et al.  An integrated pharmacokinetic and pharmacodynamic study of a new drug of abuse, methylone, a synthetic cathinone sold as “bath salts” , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[28]  T. Watanabe,et al.  Sympatho-adrenal involvement in methamphetamine-induced hyperthermia through skeletal muscle hypermetabolism. , 1998, European journal of pharmacology.

[29]  M. Liechti,et al.  Monoamine transporter and receptor interaction profiles of novel psychoactive substances: Para-halogenated amphetamines and pyrovalerone cathinones , 2015, European Neuropsychopharmacology.

[30]  K. Houseknecht,et al.  Changes in ambient temperature differentially alter the thermoregulatory, cardiac and locomotor stimulant effects of 4-methylmethcathinone (mephedrone). , 2013, Drug and alcohol dependence.

[31]  I. Sora,et al.  Methylone and Monoamine Transporters: Correlation with Toxicity , 2011, Current neuropharmacology.

[32]  M. Liechti,et al.  Bupropion, methylphenidate, and 3,4-methylenedioxypyrovalerone antagonize methamphetamine-induced efflux of dopamine according to their potencies as dopamine uptake inhibitors: implications for the treatment of methamphetamine dependence , 2013, BMC Research Notes.

[33]  O. Hornykiewicz,et al.  The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter. , 2015, European journal of pharmacology.

[34]  B. Roth,et al.  In Vitro Characterization of Ephedrine-Related Stereoisomers at Biogenic Amine Transporters and the Receptorome Reveals Selective Actions as Norepinephrine Transporter Substrates , 2003, Journal of Pharmacology and Experimental Therapeutics.

[35]  R. Dafters Hyperthermia following MDMA administration in rats: Effects of ambient temperature, water consumption, and chronic dosing , 1995, Physiology & Behavior.

[36]  T. Rodrigo,et al.  Neuronal changes and oxidative stress in adolescent rats after repeated exposure to mephedrone. , 2015, Toxicology and applied pharmacology.

[37]  J. Cadet,et al.  Speed kills : cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis , 2003 .

[38]  M. Colado,et al.  3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) disrupts blood-brain barrier integrity through a mechanism involving P2X7 receptors. , 2014, The international journal of neuropsychopharmacology.

[39]  M. Liechti,et al.  Pharmacological characterization of designer cathinones in vitro , 2013, British journal of pharmacology.

[40]  R. Glennon,et al.  Methcathinone: A new and potent amphetamine-like agent , 1987, Pharmacology Biochemistry and Behavior.

[41]  G. C. Wagner,et al.  Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption. , 2003, Journal of pharmacological sciences.

[42]  J. Camarasa,et al.  Repeated doses of methylone, a new drug of abuse, induce changes in serotonin and dopamine systems in the mouse , 2014, Psychopharmacology.

[43]  S. Rawls,et al.  Behavioral pharmacology of designer cathinones: a review of the preclinical literature. , 2014, Life sciences.

[44]  D. Murphy,et al.  Methylone-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters. , 2015, Behavioural pharmacology.

[45]  J. Camarasa,et al.  Interaction of mephedrone with dopamine and serotonin targets in rats , 2012, European Neuropsychopharmacology.

[46]  L. Parsons,et al.  Effect of Ambient Temperature on the Thermoregulatory and Locomotor Stimulant Effects of 4-Methylmethcathinone in Wistar and Sprague-Dawley Rats , 2012, PloS one.

[47]  D. Murphy,et al.  Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters. , 2007, European journal of pharmacology.

[48]  Stuart A. Collins,et al.  Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine. , 2014, Life sciences.

[49]  C. Ciudad,et al.  Alcohol enhances the psychostimulant and conditioning effects of mephedrone in adolescent mice; postulation of unique roles of D3 receptors and BDNF in place preference acquisition , 2015, British journal of pharmacology.

[50]  A. Stepens,et al.  The outcome of the movement disorder in methcathinone abusers: clinical, MRI and manganesemia changes, and neuropathology , 2014, European journal of neurology.

[51]  S. Rozov,et al.  Long-term cognitive and neurochemical effects of “bath salt” designer drugs methylone and mephedrone , 2013, Pharmacology Biochemistry and Behavior.

[52]  J. Kehr,et al.  Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5‐HT levels in nucleus accumbens of awake rats , 2011, British journal of pharmacology.

[53]  R. Rothman,et al.  The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue , 2012, Neuropsychopharmacology.

[54]  O. Levin ["Ephedron" encephalopathy]. , 2005, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[55]  A. Boguszewska-Czubara,et al.  Mephedrone and Nicotine: Oxidative Stress and Behavioral Interactions in Animal Models , 2015, Neurochemical Research.

[56]  R. Glennon,et al.  Quantitative structure–activity relationship analysis of the pharmacology of para‐substituted methcathinone analogues , 2015, British journal of pharmacology.

[57]  D. Kuhn,et al.  Mephedrone, an abused psychoactive component of ‘bath salts’ and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum , 2012, Journal of neurochemistry.

[58]  J. Camarasa,et al.  Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone , 2012, British journal of pharmacology.

[59]  A. Ruoho,et al.  Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines. , 1999, European journal of pharmacology.

[60]  M. Levine,et al.  Acute Methylenedioxypyrovalerone Toxicity , 2014, Journal of Medical Toxicology.

[61]  Kurt R. Lehner,et al.  Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV), a Principal Constituent of Psychoactive ‘Bath Salts’ Products , 2013, Neuropsychopharmacology.

[62]  A. Moszczynska,et al.  Amphetamine toxicities , 2010, Annals of the New York Academy of Sciences.

[63]  Kurt R. Lehner,et al.  Psychoactive "bath salts": not so soothing. , 2013, European journal of pharmacology.

[64]  F. Ebling,et al.  Contribution of serotonin and dopamine to changes in core body temperature and locomotor activity in rats following repeated administration of mephedrone , 2016, Addiction biology.

[65]  K. Rice,et al.  In vivo Effects of Abused ‘Bath Salt’ Constituent 3,4-methylenedioxypyrovalerone (MDPV) in Mice: Drug Discrimination, Thermoregulation, and Locomotor Activity , 2013, Neuropsychopharmacology.

[66]  A. Janowsky,et al.  Substituted methcathinones differ in transporter and receptor interactions. , 2013, Biochemical pharmacology.

[67]  K. Esser,et al.  Voluntary exercise protects against methamphetamine-induced oxidative stress in brain microvasculature and disruption of the blood–brain barrier , 2009, Molecular Neurodegeneration.

[68]  G. Ricaurte,et al.  Neurotoxic and pharmacologic studies on enantiomers of the N-methylated analog of cathinone (methcathinone): a new drug of abuse. , 1996, The Journal of pharmacology and experimental therapeutics.

[69]  E. Mervaala,et al.  Keto amphetamine toxicity-focus on the redox reactivity of the cathinone designer drug mephedrone. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[70]  M. Colado,et al.  Current preclinical studies on neuroinflammation and changes in blood–brain barrier integrity by MDMA and methamphetamine , 2014, Neuropharmacology.

[71]  F. Nagai,et al.  The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. , 2007, European journal of pharmacology.

[72]  N. Murakami,et al.  Cardiovascular, thermal and behavioral sensitization to methamphetamine in freely moving rats. , 1993, The Journal of pharmacology and experimental therapeutics.

[73]  J. Camarasa,et al.  Serotonergic impairment and memory deficits in adolescent rats after binge exposure of methylone , 2014, Journal of psychopharmacology.

[74]  D. Kuhn,et al.  The newly synthesized pool of dopamine determines the severity of methamphetamine‐induced neurotoxicity , 2008, Journal of neurochemistry.

[75]  R. Moratalla,et al.  Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms , 2017, Progress in Neurobiology.

[76]  A. Green,et al.  Differential effects of cathinone compounds and MDMA on body temperature in the rat, and pharmacological characterization of mephedrone‐induced hypothermia , 2013, British journal of pharmacology.

[77]  R. Glennon,et al.  Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para‐substituted methcathinone analogues , 2015, British journal of pharmacology.

[78]  P. Couraud,et al.  Carrier-Mediated Cocaine Transport at the Blood-Brain Barrier as a Putative Mechanism in Addiction Liability , 2014, The international journal of neuropsychopharmacology.

[79]  Andreas Meisel,et al.  Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview , 2009, Molecular Neurobiology.

[80]  K. Houseknecht,et al.  Mephedrone (4‐methylmethcathinone) supports intravenous self‐administration in Sprague‐Dawley and Wistar rats , 2013, Addiction biology.

[81]  K. Foley,et al.  Methcathinone is a substrate for the serotonin uptake transporter. , 2003, Pharmacology & toxicology.

[82]  Ana Margarida Araújo,et al.  Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of ‘legal high’ packages containing synthetic cathinones , 2014, Archives of Toxicology.

[83]  A. Riley,et al.  Age-dependent MDPV-induced taste aversions and thermoregulation in adolescent and adult rats. , 2014, Developmental psychobiology.

[84]  C. Lay,et al.  Effects of (±)3,4-methylenedioxymethamphetamine, (±)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques , 2006, Neuroscience.

[85]  D. Sulzer,et al.  Amphetamine and Other Weak Bases Act to Promote Reverse Transport of Dopamine in Ventral Midbrain Neurons , 1993, Journal of neurochemistry.

[86]  T. Dickerson,et al.  In vivo potency and efficacy of the novel cathinone α-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats , 2015, Psychopharmacology.

[87]  D. Kuhn,et al.  Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines , 2004, Neuroscience Letters.

[88]  R. Glennon,et al.  Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter , 2013, British journal of pharmacology.

[89]  G. Hanson,et al.  4-Methylmethcathinone (Mephedrone): Neuropharmacological Effects of a Designer Stimulant of Abuse , 2011, Journal of Pharmacology and Experimental Therapeutics.

[90]  M. Gygi,et al.  Methcathinone: an initial study of its effects on monoaminergic systems. , 1996, The Journal of pharmacology and experimental therapeutics.

[91]  M Coppola,et al.  Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food". , 2012, Toxicology letters.

[92]  Michael H. Baumann,et al.  3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings , 2006, Psychopharmacology.

[93]  C. Fontes-Ribeiro,et al.  The TNF-α/Nf-κB Signaling Pathway has a Key Role in Methamphetamine–Induced Blood–Brain Barrier Dysfunction , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[94]  M. Kane,et al.  Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA , 2013, Journal of neurochemistry.

[95]  B. Blough,et al.  Pharmacology of novel synthetic stimulants structurally related to the “bath salts” constituent 3,4-methylenedioxypyrovalerone (MDPV) , 2014, Neuropharmacology.

[96]  J. Kelly,et al.  Cathinone derivatives: a review of their chemistry, pharmacology and toxicology. , 2011, Drug testing and analysis.

[97]  I. McGregor,et al.  Mephedrone (4‐methylmethcathinone, ‘meow’): acute behavioural effects and distribution of Fos expression in adolescent rats , 2012, Addiction biology.